BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3448 related articles for article (PubMed ID: 7587740)

  • 21. Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.
    Munn DH; Cheung NK
    Prog Clin Biol Res; 1991; 366():389-94. PubMed ID: 2068153
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
    Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
    Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R; Okamoto S; Takahashi S; Inoue T; Kikuno K; Aoki Y; Takada M; Irie S; Shimane M; Tojo A
    Rinsho Ketsueki; 1993 Aug; 34(8):946-51. PubMed ID: 8105115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
    Høgåsen AK; Hestdal K; Abrahamsen TG
    J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
    Pangault C; Le Tulzo Y; Tattevin P; Guilloux V; Bescher N; Drénou B
    Crit Care Med; 2006 Apr; 34(4):1193-201. PubMed ID: 16484916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes.
    Hashimoto S; Yoda M; Yamada M; Yanai N; Kawashima T; Motoyoshi K
    Exp Hematol; 1996 Feb; 24(2):123-8. PubMed ID: 8641333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
    Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
    Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
    Sakurai T; Yamada M; Simamura S; Motoyoshi K
    Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).
    VandePol CJ; Garnick MB
    Biotechnol Ther; 1991; 2(3-4):231-9. PubMed ID: 1845128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
    Chen J; Zhou JH; Ball ED
    Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.
    Mels AK; Statius Muller MG; van Leeuwen PA; von Blomberg BM; Scheper RJ; Cuesta MA; Beelen RH; Meijer S
    Br J Surg; 2001 Apr; 88(4):539-44. PubMed ID: 11298622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
    Roth MD; Gitlitz BJ; Kiertscher SM; Park AN; Mendenhall M; Moldawer N; Figlin RA
    Cancer Res; 2000 Apr; 60(7):1934-41. PubMed ID: 10766183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopathology of metastases in patients of colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factor.
    Shetye J; Ragnhammar P; Liljefors M; Christensson B; Frödin JE; Biberfeld P; Mellstedt H
    Clin Cancer Res; 1998 Aug; 4(8):1921-9. PubMed ID: 9717820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
    Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
    Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
    Munn DH; Garnick MB; Cheung NK
    Blood; 1990 May; 75(10):2042-8. PubMed ID: 2186820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine-regulated expression of activated leukocyte cell adhesion molecule (CD166) on monocyte-lineage cells and in rheumatoid arthritis synovium.
    Levesque MC; Heinly CS; Whichard LP; Patel DD
    Arthritis Rheum; 1998 Dec; 41(12):2221-9. PubMed ID: 9870879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of macrophage colony-stimulating factor on the activities of murine monocytes and peritoneal macrophages in vivo.
    Katsura Y; Tsuru S; Noritake M; Shinomiya N; Kayashima S; Motoyoshi K; Rokutanda M
    Nat Immun; 1992; 11(3):167-76. PubMed ID: 1392404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 173.